We previously showed that immunisation with an adjuvant containing TLR9 and NOD2 ligands significantly prolonged survival in EOC tumour-bearing mice.31 Therefore, we asked whether mtDNA activated DCs and whether activation was TLR9-dependent. This evidence concerns the gene NOD2 and neoplasm.